The efficacy and drug survival of the biosimilar infliximab (CT-P13) compared to the original reference infliximab in inflammatory rheumatic diseases; results from the Turkbio registry
Date
2018-06
Journal Title
Journal ISSN
Volume Title
Publisher
BMJ Publishing Group
Abstract
Description
Bu çalışma, 13-16 Haziran 2018 tarihlerinde Amsterdan[Hollanda]’da düzenlenen Congress of the European-League-Against-Rheumatism (EULAR) Kongresi‘nde bildiri olarak sunulmuştur.
Keywords
Rheumatology
Citation
Uslu, S. vd. (2018). ''The efficacy and drug survival of the biosimilar infliximab (CT-P13) compared to the original reference infliximab in inflammatory rheumatic diseases; results from the Turkbio registry''. Annals of the Rheumatic Diseases, 77(Supplement 2), 329-329.